BridgeBio Pharma
BBIO
$27.03
Share price
5.50%
Change (1 day)
88.49%
Change (1 year)
Categories
Revenue for BridgeBio Pharma (BBIO)
Revenue in 2023 (TTM): $9.3 M
According to BridgeBio Pharma
's latest financial reports the company's current revenue (TTM
) is $9.3 M.
In 2022 the company made a revenue of $77.64 M an increase over the years 2021 revenue that were of $69.71 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BridgeBio Pharma from 2018 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $9.3 M | -88.02% |
| 2022 | $77.64 M | 11.38% |
| 2021 | $69.71 M | 745.14% |
| 2020 | $8.24 M | -79.66% |
| 2019 | $40.56 M | |
| 2018 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.86 B | 9,181.89% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.22 M | -97.57% | 🇺🇸 USA |